8-K filed Feb 10, 2026
Quest Diagnostics authorizes $1B for stock buybacks
“Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization”
From Quest Diagnostics’s 8-K filed Feb 10, 2026 · read the filing · all documents
How big is it?
Quest Diagnostics bought back $552M of stock in the twelve months to Jun 30, 2026. At that pace, $1.0B covers about 1.8 years of buybacks.
The amount equals 74% of its free cash flow over the same twelve months ($1.3B).
Its diluted share count is down 0.9% from a year earlier.
An authorization is permission, not a promise: the company can buy less, more slowly, or not at all, and usually doesn't have to say when it buys.
Show as table
| Period | Value |
|---|---|
| Q3 '23 | $0 |
| Q4 '23 | $0 |
| Q1 '24 | $0 |
| Q2 '24 | $0 |
| Q3 '24 | $0 |
| Q4 '24 | $0 |
| Q1 '25 | $0 |
| Q2 '25 | $0 |
| Q3 '25 | $150M |
| Q4 '25 | $302M |
| Q1 '26 | $0 |
| Q2 '26 | $100M |